Top Markets
Coin of the day
DiaSorin S.p.A. DiaSorin S.p.A.

DiaSorin S.p.A.

DIA
Classifica tra le azioni #3923
DiaSorin S.p.A. engages in research and development, manufacture, and... DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Prezzo delle azioni
$89.96
Capitalizzazione di mercato
$4.45B
Variazione (1 giorno)
-0.16%
Variazione (1 anno)
-14.59%
Paese
IT
Scambia DiaSorin S.p.A. (DIA)

Categoria

Rapporto P/B per DiaSorin S.p.A. (DIA)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di DiaSorin S.p.A., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per DiaSorin S.p.A. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
5.9029 -
US